Cardio Diagnostics Holdings, Inc. (CDIO) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 359.20K USD | Liabilities, Current |
| Cash and equivalents | 0.00 USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 3.90K USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $359.20K | $0.00 | (m) | $3.90K | (m) | (m) |
| 2026-03-31 | (m) | $491.44K | $0.00 | (m) | $4.27K | (m) | (m) |
| 2025-12-31 | (m) | $604.84K | $0.00 | (m) | $8.13K | (m) | (m) |
| 2025-09-30 | (m) | $398.45K | $0.00 | (m) | $11.22K | (m) | (m) |
| 2025-06-30 | (m) | $369.60K | $0.00 | (m) | $12.93K | (m) | (m) |
| 2025-03-31 | (m) | $540.62K | $0.00 | (m) | $9.55K | (m) | (m) |
| 2024-12-31 | (m) | $631.70K | $0.00 | (m) | $18.61K | (m) | (m) |
| 2024-09-30 | (m) | $308.68K | $0.00 | (m) | $14.10K | (m) | (m) |
| 2024-06-30 | (m) | $376.10K | $0.00 | (m) | $7.52K | (m) | (m) |
| 2024-03-31 | (m) | $685.67K | $0.00 | (m) | $18.99K | (m) | (m) |
| 2023-12-31 | (m) | $841.14K | (m) | (m) | $4.96K | (m) | (m) |
| 2023-09-30 | (m) | $2.96M | $0.00 | (m) | $350.00 | (m) | (m) |
| 2023-06-30 | (m) | (m) | $0.00 | (m) | $1.05K | (m) | (m) |
| 2023-03-31 | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | (m) | $0.00 | (m) | $0.00 | (m) | (m) |
| 2022-09-30 | (m) | $631.75K | $0.00 | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | $229.43K | $0.00 | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | $180.54K | $0.00 | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | $124.43K | $0.00 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |